v3.26.1
ORGANIZATION AND OPERATIONS - Common Control Mergers (Details Narrative)
12 Months Ended
Dec. 31, 2025
shares
Dec. 31, 2025
shares
Common Stock [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares 204,205,027  
Preferred Stock [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares   5,000,000
Nika Bio Technology [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Percentage of Equity , Before Business Combination 40.00% 40.00%
Percentage of Voting Equity Interests By Merger 80.00% 80.00%
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares 204,205,027  
Nika Pharmaceuticals, Inc.    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Percentage of Equity , Before Business Combination 40.00% 40.00%